Wells Fargo & Company En V Veno Medical Corp Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in En V Veno Medical Corp stock. As of the latest transaction made, Wells Fargo & Company holds 2,000 shares of NVNO stock, worth $5,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$5,760
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NVNO
# of Institutions
40Shares Held
4.66MCall Options Held
76KPut Options Held
100-
Kingdon Capital Management, L.L.C. New York, NY859KShares$2.47 Million0.41% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT597KShares$1.72 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA589KShares$1.7 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.16 Million3.48% of portfolio
-
Altium Capital Management LP New York, NY310KShares$892,8000.3% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $27.3M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...